MarketPeel
Insider Trading Intelligence
MS

Mary T. Szela

TLSI
CEO AND PRESIDENT · TRISALUS LIFE SCIENCES, INC. · CIK 0001410289
FILING MIX · LIFETIME88%/12%
BUYS
38
SELLS
5
TOTAL VALUE
$1.98M
COMPANIES
4
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
1,172,483
AVG SELL PX
$13.89
TRADE KIND
SHOWING 43 / 43
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 17 pending
Forward-return performance of every backtestable P/S trade by Mary T. Szela, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+66.67%-0.70%+0.10%-0.81%-0.40%
14d12+50.00%-0.80%+0.72%-1.52%-0.32%
30d12+33.33%+0.54%+1.44%-0.90%-0.02%
60d12+41.67%-0.94%+2.90%-3.85%-4.63%
90d12+50.00%-7.20%+2.61%-7.31%-20.03%
180d12(3 pending)+33.33%-2.05%+5.18%-7.23%-13.11%
1y12(3 pending)+22.22%-4.45%+19.47%-23.92%-20.07%
2y12(11 pending)+100.00%-61.90%+24.07%-85.96%-85.96%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TLSI · 1,077,683 shares · as of Jun 30, 2026
0394,546789,0911,183,6371,578,182202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 38 buys / 5 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASEGRANT
Stock grant
3,990$3.87$15.4K1,077,683Jun 30, 2026Jul 1, 2026View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
35,00035,000Jun 4, 2026Jun 4, 2026View →
ABSI
ABSCI CORP
PURCHASEGRANT
Stock grant
39,80039,800Jun 4, 2026Jun 8, 2026View →
ABSI
ABSCI CORP
PURCHASEGRANT
Stock grant
10,10010,100Jun 4, 2026Jun 8, 2026View →
ABSI
ABSCI CORP
PURCHASEGRANT
Stock grant
8,4008,400Jun 4, 2026Jun 15, 2026View →
ABSI
ABSCI CORP
PURCHASEGRANT
Stock grant
33,20033,200Jun 4, 2026Jun 15, 2026View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASE
CEO and President
39,682$2.59$102.8K1,065,215May 15, 2026May 18, 2026View →
TLSI
TRISALUS LIFE SCIENCES, INC.
SALE
CEO and President
15,944$3.85$61.4K752,987Mar 17, 2026Mar 20, 2026View →
TLSI
TRISALUS LIFE SCIENCES, INC.
SALE
CEO and President
4,358$4.13$18.0K768,931Mar 11, 2026Mar 20, 2026View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASE
CEO and President
30,487$4.10$125.0K773,289Feb 23, 2026Feb 23, 2026View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASEGRANT
Stock grant
300,000742,802Nov 24, 2025Nov 25, 2025View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASEGRANT
Stock grant
250,0001,578,182Nov 24, 2025Nov 25, 2025View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASEGRANT
Stock grant
125,000442,802Nov 24, 2025Nov 25, 2025View →
ABSI
ABSCI CORP
PURCHASEGRANT
Stock grant
178,400178,400Jul 7, 2025Jul 9, 2025View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
28,50028,500Jun 5, 2025Jun 6, 2025View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASEGRANT
Stock grant
21,089465,348Feb 18, 2025Feb 19, 2025View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASE
CEO AND PRESIDENT
5,010$5.28$26.5K444,259Jan 30, 2025Jan 31, 2025View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASE
CEO AND PRESIDENT
5,030$5.03$25.3K439,249Jan 29, 2025Jan 31, 2025View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASE
CEO AND PRESIDENT
4,716$5.12$24.1K434,219Jan 28, 2025Jan 29, 2025View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASEGRANT
Stock grant
40,000424,677Jan 27, 2025Jan 29, 2025View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASE
CEO AND PRESIDENT
4,826$5.42$26.2K429,503Jan 27, 2025Jan 29, 2025View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASEGRANT
Stock grant
240,000240,000Jan 27, 2025Jan 29, 2025View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASE
CEO AND PRESIDENT
6,000$5.00$30.0K384,677Sep 13, 2024Sep 13, 2024View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASE
CEO AND PRESIDENT
1,295$4.83$6.3K378,677Sep 13, 2024Sep 13, 2024View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASE
CEO AND PRESIDENT
7,520$5.20$39.1K377,382Sep 12, 2024Sep 13, 2024View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASE
CEO AND PRESIDENT
5,000$4.97$24.9K369,862Sep 10, 2024Sep 12, 2024View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
26,00026,000Jun 5, 2024Jun 7, 2024View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASEGRANT
Stock grant
125,000317,802Feb 13, 2024Nov 25, 2025View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASEGRANT
Stock grant
84,899364,862Feb 13, 2024Feb 14, 2024View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASEGRANT
Stock grant
288,750288,750Feb 13, 2024Feb 14, 2024View →
TLSI
TRISALUS LIFE SCIENCES, INC.
PURCHASEGRANT
Stock grant
172,500172,500Aug 14, 2023Aug 14, 2023View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
26,00026,000May 31, 2023Jun 2, 2023View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
23,00023,000Jun 21, 2022Jun 23, 2022View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
23,00023,000Jun 22, 2021Jun 23, 2021View →
CHRS
COHERUS ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
20,00020,000Jan 11, 2021Jan 13, 2021View →
KURA
KURA ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
23,00023,000Jun 24, 2020Jun 26, 2020View →
CHRS
COHERUS ONCOLOGY, INC.
PURCHASE
20,000$10.05$201.0K34,997Jun 22, 2020Jun 23, 2020View →
CHRS
COHERUS ONCOLOGY, INC.
PURCHASE
14,997$2.50$37.5K14,997Jun 22, 2020Jun 23, 2020View →
CHRS
COHERUS ONCOLOGY, INC.
SALE
20,0000Jun 22, 2020Jun 23, 2020View →
CHRS
COHERUS ONCOLOGY, INC.
PURCHASE
20,000$12.37$247.4K54,997Jun 22, 2020Jun 23, 2020View →
CHRS
COHERUS ONCOLOGY, INC.
SALE
14,9970Jun 22, 2020Jun 23, 2020View →
CHRS
COHERUS ONCOLOGY, INC.
SALE
54,997$17.58$966.8K0Jun 22, 2020Jun 23, 2020View →
CHRS
COHERUS ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
20,00020,000Jan 10, 2020Jan 14, 2020View →
Other insiders · TLSI
Loading peer insiders…
About this filer
CIK 0001410289
ROLE
CEO AND PRESIDENT
PRIMARY
TLSI
COMPANIES
4
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001410289DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback